In a statement here tonight, he said it was "not fair" to paint him as opposed to the traditional medicine, said to improve immunity, following his tweet to his fan clubs.
Haasan said he had put out a tweet yesterday only because a controversy had erupted over the use of 'nilavembu' concoction being given as part of treatment for dengue fever, which has affected a large number of people in Tamil Nadu in recent weeks.
"... that its being spread as if Kamal Haasan is opposed to nilavembu is not fair," he said
The actor said he was being critical only of the medicine being given sans proper doctors' guidance and said he welcomed any initiative benefiting people.
Haasan said he did not discriminate between any branches of medicine.
Taking a swipe at the AIADMK government over the spread of dengue, he sarcastically remarked using a Tamil saying that preventive steps could have been put in place earlier.
In Madurai, senior BJP leader L Ganesan criticised Haasan, saying his remarks on nilavembu was 'unwarranted'.
"His statement is unwarranted when the Tamil Nadu government is taking serious steps to control dengue fever and bring it under control. There is no need to do research on 'nilavembu' now," the Rajya Sabha member told reporters there.
The actor had made the statement just for the "sake of making a statement with a difference," he added.
Ganesan also said there was a strong possibility of the proposed All India Institute of Medical Sciences (AIIMS) being located in Madurai District.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
